跳至主要内容
临床试验/CTRI/2026/01/101806
CTRI/2026/01/101806尚未招募1 期

Effectiveness Of Tellurium Metallicum In LM Potencies For Management Of Tinea Corporis Among Patients Aged 20 To 50 Years By Using TCS: A Prospective Single Arm Study

Parul Institute of Homoeopathy and Research1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2026年3月2日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
32
试验地点
1

研究概览

简要总结

Tinea corporis is a common and recurrent superficial fungal infection in India, particularly affecting individuals aged 20–50 years, with growing resistance and adverse effects associated with conventional antifungal therapies. Tellurium metallicum, a well-indicated homoeopathic remedy for ring-shaped, pruritic, and offensive skin lesions, closely corresponds to the clinical presentation of tinea corporis; however, clinical evidence for its effectiveness in LM potencies remains limited. This prospective single-arm study aims to evaluate the effectiveness of Tellurium metallicum in LM potencies for the management of tinea corporis using the Tinea Corporis Score (TCS). A total of 32 clinically diagnosed patients (ICD-10 CM B35.4), aged 20–50 years, will be enrolled through purposive sampling from the OPD and IPD of Parul Institute of Homoeopathy and Research Hospital, Vadodara. Tellurium metallicum will be administered orally in liquid form, starting from LM 0/1 and adjusted according to clinical response, with weekly follow-up for up to 6 weeks. Treatment outcomes will be assessed using TCS, and the collected data will be statistically analyzed to determine the clinical effectiveness of the intervention.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Cases which are clinically diagnosed according to ICD-10 CM, B35.4 criteria.
  • All socio-economic status.
  • Patient who will provide informed consent.

排除标准

  • Patient who are taking simultaneously any other treatment for the tinea corporis.
  • Patients with any type of severe systemic illnesses.
  • Pregnant and lactating women.

研究者

发起方
Parul Institute of Homoeopathy and Research
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Ishita Jignesh Khant

Parul Institute of Homoeopathy and Research Hospital

研究点 (1)

Loading locations...

相似试验

A Clinical Study To Evaluate The Effect Of The... | 临床试验